Little is known about the epidemiology of Toxoplasma gondii and Neospora caninum infections in alpacas (Vicugna pacos) and llamas (Lama glama) outside South America. The study aimed to estimate the seroprevalence of T. gondii and N. caninum infections in South American camelids (SAC) in Switzerland, to optimize serological tests for SAC and to identify risk factors, which may favour infection.
A total of 571 sera from 132 Swiss farms (374 alpacas and 197 llamas, mean 4.3 animals/farm) were obtained. Four commercial enzyme-linked immunosorbent assays (ELISA) for detecting antibodies against T. gondii (ID Screen® Toxoplasmosis Indirect (TOXO-MS)) or N. caninum (i.e. ID Screen® Neospora caninum Indirect Multi-species (NCS-MS); ID Screen® Neospora caninum Competition (NCC) and ID Screen® Neospora caninum Indirect (NCS)) were first assessed for their use on SAC comparing their results with those in immunoblot, and optimizing cut-offs. Subsequently, two kits (TOXO-MS and NCS-MS) were selected for seroprevalence estimation. Additionally, a risk factor analysis for infection was performed on 41 farms, which agreed to participate in a web-based survey.
NLg919 |
|||
20-abx182602 | Abbexa |
|
|
NLG919 |
|||
A4373-10 | ApexBio | 10 mg | EUR 84 |
Description: Potent IDO pathway inhibitor |
NLG919 |
|||
A4373-5.1 | ApexBio | 10 mM (in 1mL DMSO) | EUR 92 |
Description: Potent IDO pathway inhibitor |
NLG919 |
|||
A4373-50 | ApexBio | 50 mg | EUR 304 |
Description: Potent IDO pathway inhibitor |
NLG919 |
|||
N630000 | Toronto Research Chemicals | 50mg | EUR 626 |
Description: 1402836-58-1 |
NLG919-d10 |
|||
N630002 | Toronto Research Chemicals | 10mg | EUR 224 |
NLG919 (GDC-0919) |
|||
206165 | MedKoo Biosciences | 10.0mg | EUR 150 |
Indoximod (NLG-8189) |
|||
B4900-200 | ApexBio | 200 mg | EUR 46 |
Description: Indoleamine 2,3-dioxygenase (IDO) pathway inhibitor |
Indoximod (NLG-8189) |
|||
B4900-50 | ApexBio | 50 mg | EUR 28 |
Description: Indoleamine 2,3-dioxygenase (IDO) pathway inhibitor |
NLG802 |
|||
T39476-10mg | TargetMol Chemicals | 10mg | Ask for price |
Description: NLG802 |
NLG802 |
|||
T39476-1g | TargetMol Chemicals | 1g | Ask for price |
Description: NLG802 |
NLG802 |
|||
T39476-1mg | TargetMol Chemicals | 1mg | Ask for price |
Description: NLG802 |
NLG802 |
|||
T39476-50mg | TargetMol Chemicals | 50mg | Ask for price |
Description: NLG802 |
NLG802 |
|||
T39476-5mg | TargetMol Chemicals | 5mg | Ask for price |
Description: NLG802 |
Nlg4 Antibody |
|||
SAB376 | SAB | 100ul | EUR 319 |
Nlg2 Antibody |
|||
SAB382 | SAB | 100ul | EUR 319 |
Nlg2 Antibody |
|||
SAB383 | SAB | 100ul | EUR 319 |
Nlg2 Antibody |
|||
SAB384 | SAB | 100ul | EUR 319 |
Nlg2 Antibody |
|||
SAB409 | SAB | 100ul | EUR 319 |
Nlg2 Antibody |
|||
SAB410 | SAB | 100ul | EUR 319 |
Nlg2 Antibody |
|||
SAB411 | SAB | 100ul | EUR 319 |
Rabbit Anti-Human Filtrin/NLG1 IgG #1, aff pure |
|||
NLG11-A | Alpha Diagnostics | 100 ug | EUR 578.4 |
Nlgn2/ Rat Nlgn2 ELISA Kit |
|||
ELI-46170r | Lifescience Market | 96 Tests | EUR 1063.2 |
Nlgn1/ Rat Nlgn1 ELISA Kit |
|||
ELI-20702r | Lifescience Market | 96 Tests | EUR 1063.2 |
Human Filtrin/NLG1 Control/blocking peptide #1 |
|||
NLG11-P | Alpha Diagnostics | 100 ug | EUR 196.8 |
Recombinant Caenorhabditis Elegans nlg-1 Protein (aa 18-798) |
|||
VAng-Ly3572-inquire | Creative Biolabs | inquire | Ask for price |
Description: Caenorhabditis Elegans neuroligin-1 (nlg-1), partial, recombination protein. |
Nlgn1 (untagged ORF) - Rat neuroligin 1 (Nlgn1), (10 ug) |
|||
RN200719 | Origene Technologies GmbH | 10 µg | Ask for price |
Nlgn2 (untagged ORF) - Rat neuroligin 2 (Nlgn2), (10 ug) |
|||
RN210792 | Origene Technologies GmbH | 10 µg | Ask for price |
Nlgn3 (untagged ORF) - Rat neuroligin 3 (Nlgn3), (10 ug) |
|||
RN213549 | Origene Technologies GmbH | 10 µg | Ask for price |
NLGN1 (untagged)-Human neuroligin 1 (NLGN1) |
|||
SC127261 | Origene Technologies GmbH | 10 µg | Ask for price |
NLGN1 (untagged)-Human neuroligin 1 (NLGN1) |
|||
SC324313 | Origene Technologies GmbH | 10 µg | Ask for price |
NLGN2 (untagged)-Human neuroligin 2 (NLGN2) |
|||
SC314795 | Origene Technologies GmbH | 10 µg | Ask for price |
NLGN2 (GFP-tagged) - Human neuroligin 2 (NLGN2) |
|||
RG222544 | Origene Technologies GmbH | 10 µg | Ask for price |
NLGN1 (GFP-tagged) - Human neuroligin 1 (NLGN1) |
|||
RG207524 | Origene Technologies GmbH | 10 µg | Ask for price |
Nlgn2 (untagged) - Mouse neuroligin 2 (Nlgn2), (10ug) |
|||
MC221962 | Origene Technologies GmbH | 10 µg | Ask for price |
Nlgn3 (untagged) - Mouse neuroligin 3 (Nlgn3), (10ug) |
|||
MC221904 | Origene Technologies GmbH | 10 µg | Ask for price |
Nlgn3 (GFP-tagged) - Mouse neuroligin 3 (Nlgn3), (10ug) |
|||
MG222086 | Origene Technologies GmbH | 10 µg | Ask for price |
Nlgn2 (GFP-tagged) - Mouse neuroligin 2 (Nlgn2), (10ug) |
|||
MG222168 | Origene Technologies GmbH | 10 µg | Ask for price |
Nlgn1 (Myc-DDK-tagged ORF) - Rat neuroligin 1 (Nlgn1), (10 ug) |
|||
RR200719 | Origene Technologies GmbH | 10 µg | Ask for price |
Nlgn2 (Myc-DDK-tagged ORF) - Rat neuroligin 2 (Nlgn2), (10 ug) |
|||
RR210792 | Origene Technologies GmbH | 10 µg | Ask for price |
Nlgn3 (Myc-DDK-tagged ORF) - Rat neuroligin 3 (Nlgn3), (10 ug) |
|||
RR213549 | Origene Technologies GmbH | 10 µg | Ask for price |
Nlgn3 (Myc-DDK-tagged) - Mouse neuroligin 3 (Nlgn3) |
|||
MR222086 | Origene Technologies GmbH | 10 µg | Ask for price |
Nlgn2 (Myc-DDK-tagged) - Mouse neuroligin 2 (Nlgn2) |
|||
MR222168 | Origene Technologies GmbH | 10 µg | Ask for price |
NLGN1 (Myc-DDK-tagged)-Human neuroligin 1 (NLGN1) |
|||
RC207524 | Origene Technologies GmbH | 10 µg | Ask for price |
NLGN2 (Myc-DDK-tagged)-Human neuroligin 2 (NLGN2) |
|||
RC222544 | Origene Technologies GmbH | 10 µg | Ask for price |
Lenti ORF clone of Nlgn1 (mGFP-tagged ORF) - Rat neuroligin 1 (Nlgn1), (10 ug) |
|||
RR200719L4 | Origene Technologies GmbH | 10 µg | Ask for price |
Lenti ORF clone of Nlgn2 (mGFP-tagged ORF) - Rat neuroligin 2 (Nlgn2), (10 ug) |
|||
RR210792L4 | Origene Technologies GmbH | 10 µg | Ask for price |
Lenti ORF clone of Nlgn3 (mGFP-tagged ORF) - Rat neuroligin 3 (Nlgn3), (10 ug) |
|||
RR213549L4 | Origene Technologies GmbH | 10 µg | Ask for price |
NLGN3 |
|||
CSB-CL873703HU | Cusabio | 10 μg plasmid + 200μl Glycerol | Ask for price |
NLGN1 |
|||
CSB-CL839786HU | Cusabio | 10 μg plasmid + 200μl Glycerol | Ask for price |
Lenti ORF clone of Nlgn3 (mGFP-tagged) - Mouse neuroligin 3 (Nlgn3) |
|||
MR222086L4 | Origene Technologies GmbH | 10 µg | Ask for price |
Lenti ORF clone of Nlgn2 (mGFP-tagged) - Mouse neuroligin 2 (Nlgn2) |
|||
MR222168L4 | Origene Technologies GmbH | 10 µg | Ask for price |
Lenti ORF clone of Nlgn1 (Myc-DDK-tagged ORF) - Rat neuroligin 1 (Nlgn1), (10 ug) |
|||
RR200719L3 | Origene Technologies GmbH | 10 µg | Ask for price |
Lenti ORF clone of Nlgn2 (Myc-DDK-tagged ORF) - Rat neuroligin 2 (Nlgn2), (10 ug) |
|||
RR210792L3 | Origene Technologies GmbH | 10 µg | Ask for price |
Lenti ORF clone of Nlgn3 (Myc-DDK-tagged ORF) - Rat neuroligin 3 (Nlgn3), (10 ug) |
|||
RR213549L3 | Origene Technologies GmbH | 10 µg | Ask for price |
NLGN4Y |
|||
CSB-CL818786HU1 | Cusabio | 10 μg plasmid + 200μl Glycerol | Ask for price |
NLGN4Y |
|||
CSB-CL818786HU2 | Cusabio | 10 μg plasmid + 200μl Glycerol | Ask for price |
NLGN4X |
|||
CSB-CL843131HU | Cusabio | 10 μg plasmid + 200μl Glycerol | Ask for price |
Lenti ORF clone of Nlgn3 (Myc-DDK-tagged) - Mouse neuroligin 3 (Nlgn3) |
|||
MR222086L3 | Origene Technologies GmbH | 10 µg | Ask for price |
Lenti ORF clone of Nlgn2 (Myc-DDK-tagged) - Mouse neuroligin 2 (Nlgn2) |
|||
MR222168L3 | Origene Technologies GmbH | 10 µg | Ask for price |
Lenti-ORF clone of NLGN2 (mGFP-tagged)-Human neuroligin 2 (NLGN2) |
|||
RC222544L2 | Origene Technologies GmbH | 10 µg | Ask for price |
Lenti-ORF clone of NLGN2 (mGFP-tagged)-Human neuroligin 2 (NLGN2) |
|||
RC222544L4 | Origene Technologies GmbH | 10 µg | Ask for price |
Lenti-ORF clone of NLGN2 (Myc-DDK-tagged)-Human neuroligin 2 (NLGN2) |
|||
RC222544L1 | Origene Technologies GmbH | 10 µg | Ask for price |
Lenti-ORF clone of NLGN2 (Myc-DDK-tagged)-Human neuroligin 2 (NLGN2) |
|||
RC222544L3 | Origene Technologies GmbH | 10 µg | Ask for price |
Lenti ORF particles, Nlgn1 (GFP-tagged ORF) - Rat neuroligin 1 (Nlgn1), 200ul, >10^7 TU/mL |
|||
RR200719L4V | Origene Technologies GmbH | 200 µl | Ask for price |
NLGN3 (untagged)-Human neuroligin 3 (NLGN3), transcript variant 2 |
|||
SC113280 | Origene Technologies GmbH | 10 µg | Ask for price |
Lenti ORF particles, Nlgn2 (GFP-tagged ORF) - Rat neuroligin 2 (Nlgn2), 200ul, >10^7 TU/mL |
|||
RR210792L4V | Origene Technologies GmbH | 200 µl | Ask for price |
Lenti ORF particles, Nlgn3 (GFP-tagged ORF) - Rat neuroligin 3 (Nlgn3), 200ul, >10^7 TU/mL |
|||
RR213549L4V | Origene Technologies GmbH | 200 µl | Ask for price |
NLGN3 (untagged)-Human neuroligin 3 (NLGN3) transcript variant 3 |
|||
SC329144 | Origene Technologies GmbH | 10 µg | Ask for price |
NLGN3 (untagged)-Human neuroligin 3 (NLGN3) transcript variant 1 |
|||
SC329177 | Origene Technologies GmbH | 10 µg | Ask for price |
Lenti ORF particles, Nlgn3 (GFP-tagged) - Mouse neuroligin 3 (Nlgn3), 200ul, >10^7 TU/mL |
|||
MR222086L4V | Origene Technologies GmbH | 200 µl | Ask for price |
Lenti ORF particles, Nlgn2 (GFP-tagged) - Mouse neuroligin 2 (Nlgn2), 200ul, >10^7 TU/mL |
|||
MR222168L4V | Origene Technologies GmbH | 200 µl | Ask for price |
NLGN3 (GFP-tagged) - Human neuroligin 3 (NLGN3), transcript variant 3 |
|||
RG230506 | Origene Technologies GmbH | 10 µg | Ask for price |
NLGN3 (GFP-tagged) - Human neuroligin 3 (NLGN3), transcript variant 1 |
|||
RG230539 | Origene Technologies GmbH | 10 µg | Ask for price |
NLGN3 (GFP-tagged) - Human neuroligin 3 (NLGN3), transcript variant 2 |
|||
RG207955 | Origene Technologies GmbH | 10 µg | Ask for price |
NLGN1 siRNA |
|||
20-abx925994 | Abbexa |
|
|
NLGN1 siRNA |
|||
20-abx925995 | Abbexa |
|
|
NLGN2 siRNA |
|||
20-abx925996 | Abbexa |
|
|
NLGN2 siRNA |
|||
20-abx925997 | Abbexa |
|
|
NLGN3 siRNA |
|||
20-abx925998 | Abbexa |
|
|
NLGN3 siRNA |
|||
20-abx925999 | Abbexa |
|
|
NLGN1 siRNA |
|||
20-abx903571 | Abbexa |
|
|
NLGN2 siRNA |
|||
20-abx903572 | Abbexa |
|
|
NLGN3 siRNA |
|||
20-abx903573 | Abbexa |
|
|
Nlgn1 (untagged) - Mouse neuroligin 1 (Nlgn1), transcript variant 1, (10ug) |
|||
MC222019 | Origene Technologies GmbH | 10 µg | Ask for price |
Nlgn1 (untagged) - Mouse neuroligin 1 (Nlgn1), transcript variant 2, (10ug) |
|||
MC221824 | Origene Technologies GmbH | 10 µg | Ask for price |
Lenti ORF particles, NLGN1 (Myc-DDK tagged) - Human neuroligin 1 (NLGN1), 200ul, >10^7 TU/mL |
|||
RC207524L1V | Origene Technologies GmbH | 200 µl | Ask for price |
Lenti ORF particles, NLGN1 (mGFP-tagged) - Human neuroligin 1 (NLGN1), 200ul, >10^7 TU/mL |
|||
RC207524L2V | Origene Technologies GmbH | 200 µl | Ask for price |
Lenti ORF particles, NLGN1 (Myc-DDK tagged) - Human neuroligin 1 (NLGN1), 200ul, >10^7 TU/mL |
|||
RC207524L3V | Origene Technologies GmbH | 200 µl | Ask for price |
Lenti ORF particles, NLGN1 (mGFP-tagged) - Human neuroligin 1 (NLGN1), 200ul, >10^7 TU/mL |
|||
RC207524L4V | Origene Technologies GmbH | 200 µl | Ask for price |
Lenti ORF particles, NLGN2 (mGFP-tagged)-Human neuroligin 2 (NLGN2), 200ul, >10^7 TU/mL |
|||
RC222544L2V | Origene Technologies GmbH | 200 µl | Ask for price |
Lenti ORF particles, NLGN2 (mGFP-tagged)-Human neuroligin 2 (NLGN2), 200ul, >10^7 TU/mL |
|||
RC222544L4V | Origene Technologies GmbH | 200 µl | Ask for price |
Nlgn1 (GFP-tagged) - Mouse neuroligin 1 (Nlgn1) transcript variant 1, (10ug) |
|||
MG226624 | Origene Technologies GmbH | 10 µg | Ask for price |
Nlgn1 (GFP-tagged) - Mouse neuroligin 1 (Nlgn1) transcript variant 2, (10ug) |
|||
MG226628 | Origene Technologies GmbH | 10 µg | Ask for price |
Lenti ORF particles, Nlgn1 (Myc-DDK-tagged ORF) - Rat neuroligin 1 (Nlgn1), 200ul, >10^7 TU/mL |
|||
RR200719L3V | Origene Technologies GmbH | 200 µl | Ask for price |
Lenti ORF particles, Nlgn2 (Myc-DDK-tagged ORF) - Rat neuroligin 2 (Nlgn2), 200ul, >10^7 TU/mL |
|||
RR210792L3V | Origene Technologies GmbH | 200 µl | Ask for price |
Lenti ORF particles, Nlgn3 (Myc-DDK-tagged ORF) - Rat neuroligin 3 (Nlgn3), 200ul, >10^7 TU/mL |
|||
RR213549L3V | Origene Technologies GmbH | 200 µl | Ask for price |
NLGN4X siRNA |
|||
20-abx926000 | Abbexa |
|
|
NLGN4Y siRNA |
|||
20-abx926001 | Abbexa |
|
|
Nlgn1 (Myc-DDK-tagged) - Mouse neuroligin 1 (Nlgn1), transcript variant 1 |
|||
MR226624 | Origene Technologies GmbH | 10 µg | Ask for price |
Nlgn1 (Myc-DDK-tagged) - Mouse neuroligin 1 (Nlgn1), transcript variant 2 |
|||
MR226628 | Origene Technologies GmbH | 10 µg | Ask for price |
Lenti ORF particles, Nlgn3 (Myc-DDK-tagged) - Mouse neuroligin 3 (Nlgn3), 200ul, >10^7 TU/mL |
|||
MR222086L3V | Origene Technologies GmbH | 200 µl | Ask for price |
Lenti ORF particles, Nlgn2 (Myc-DDK-tagged) - Mouse neuroligin 2 (Nlgn2), 200ul, >10^7 TU/mL |
|||
MR222168L3V | Origene Technologies GmbH | 200 µl | Ask for price |
NLGN3 (Myc-DDK-tagged)-Human neuroligin 3 (NLGN3), transcript variant 2 |
|||
RC207955 | Origene Technologies GmbH | 10 µg | Ask for price |
Lenti ORF particles, NLGN2 (Myc-DDK-tagged)-Human neuroligin 2 (NLGN2), 200ul, >10^7 TU/mL |
|||
RC222544L1V | Origene Technologies GmbH | 200 µl | Ask for price |
Lenti ORF particles, NLGN2 (Myc-DDK-tagged)-Human neuroligin 2 (NLGN2), 200ul, >10^7 TU/mL |
|||
RC222544L3V | Origene Technologies GmbH | 200 µl | Ask for price |
NLGN3 (Myc-DDK-tagged)-Human neuroligin 3 (NLGN3), transcript variant 3 |
|||
RC230506 | Origene Technologies GmbH | 10 µg | Ask for price |
NLGN3 (Myc-DDK-tagged)-Human neuroligin 3 (NLGN3), transcript variant 1 |
|||
RC230539 | Origene Technologies GmbH | 10 µg | Ask for price |
NLGN3 Rabbit pAb |
|||
A10310-100ul | Abclonal | 100 ul | EUR 369.6 |
NLGN3 Rabbit pAb |
|||
A10310-200ul | Abclonal | 200 ul | EUR 550.8 |
NLGN3 Rabbit pAb |
|||
A10310-20ul | Abclonal | 20 ul | EUR 219.6 |
NLGN3 Rabbit pAb |
|||
A10310-50ul | Abclonal | 50 ul | EUR 267.6 |
NLGN1 Rabbit pAb |
|||
E2516105 | EnoGene | 100ul | EUR 225 |
Description: Available in various conjugation types. |
NLGNX rabbit pAb |
|||
E28PN3554 | EnoGene | 100μl | EUR 255 |
Description: Available in various conjugation types. |
NLGN1 Rabbit pAb |
|||
A16105-100ul | Abclonal | 100 ul | EUR 369.6 |
NLGN1 Rabbit pAb |
|||
A16105-200ul | Abclonal | 200 ul | EUR 550.8 |
NLGN1 Rabbit pAb |
|||
A16105-20ul | Abclonal | 20 ul | EUR 219.6 |
NLGN1 Rabbit pAb |
|||
A16105-50ul | Abclonal | 50 ul | EUR 267.6 |
NLGN2 Rabbit pAb |
|||
A14289-100ul | Abclonal | 100 ul | EUR 369.6 |
NLGN2 Rabbit pAb |
|||
A14289-200ul | Abclonal | 200 ul | EUR 550.8 |
NLGN2 Rabbit pAb |
|||
A14289-20ul | Abclonal | 20 ul | EUR 219.6 |
NLGN2 Rabbit pAb |
|||
A14289-50ul | Abclonal | 50 ul | EUR 267.6 |
NLGN2 Rabbit pAb |
|||
A14418-100ul | Abclonal | 100 ul | EUR 369.6 |
NLGN2 Rabbit pAb |
|||
A14418-200ul | Abclonal | 200 ul | EUR 550.8 |
NLGN2 Rabbit pAb |
|||
A14418-20ul | Abclonal | 20 ul | EUR 219.6 |
NLGN2 Rabbit pAb |
|||
A14418-50ul | Abclonal | 50 ul | EUR 267.6 |
NLGN2 Peptide |
|||
7969P | ProSci | 0.05 mg | EUR 197.7 |
Description: (NT) NLGN2 Peptide |
NLGN4X (untagged)-Human neuroligin 4, X-linked (NLGN4X), transcript variant 2 |
|||
SC124784 | Origene Technologies GmbH | 10 µg | Ask for price |
NLGN4X (untagged)-Human neuroligin 4, X-linked (NLGN4X), transcript variant 1 |
|||
SC127514 | Origene Technologies GmbH | 10 µg | Ask for price |
NLGN4Y (untagged)-Human neuroligin 4, Y-linked (NLGN4Y), transcript variant 1 |
|||
SC310097 | Origene Technologies GmbH | 10 µg | Ask for price |
NLGN4X (untagged) - Human neuroligin 4, X-linked (NLGN4X), transcript variant 3 |
|||
SC337515 | Origene Technologies GmbH | 10 µg | Ask for price |
NLGN4X (untagged) - Human neuroligin 4, X-linked (NLGN4X), transcript variant 4 |
|||
SC337516 | Origene Technologies GmbH | 10 µg | Ask for price |
NLGN4X (untagged)-Human neuroligin 4, X-linked (NLGN4X), transcript variant 2 |
|||
SC320970 | Origene Technologies GmbH | 10 µg | Ask for price |
NLGN4Y (untagged)-Human neuroligin 4 Y-linked (NLGN4Y) transcript variant 2 |
|||
SC326827 | Origene Technologies GmbH | 10 µg | Ask for price |
NLGN4X Rabbit pAb |
|||
A7986-100ul | Abclonal | 100 ul | EUR 369.6 |
NLGN4X Rabbit pAb |
|||
A7986-200ul | Abclonal | 200 ul | EUR 550.8 |
NLGN4X Rabbit pAb |
|||
A7986-20ul | Abclonal | 20 ul | EUR 219.6 |
NLGN4X Rabbit pAb |
|||
A7986-50ul | Abclonal | 50 ul | EUR 267.6 |
NLGN1 Antibody |
|||
36650 | SAB | 100ul | EUR 319 |
NLGN1 Antibody |
|||
36650-100ul | SAB | 100ul | EUR 302.4 |
NLGN3 Antibody |
|||
46087-100ul | SAB | 100ul | EUR 302.4 |
NLGN3 Antibody |
|||
46087-50ul | SAB | 50ul | EUR 224.4 |
NLGN1 Antibody |
|||
46627 | SAB | 100ul | EUR 319 |
NLGN1 Antibody |
|||
46627-100ul | SAB | 100ul | EUR 302.4 |
NLGN4X Peptide |
|||
43-069P | ProSci | 0.1 mg | EUR 405.6 |
Description: NLGN4X Peptide |
NLGN2 Antibody |
|||
39957-100ul | SAB | 100ul | EUR 468 |
NLGN1 Antibody |
|||
1-CSB-PA928711 | Cusabio |
|
|
Description: A polyclonal antibody against NLGN1. Recognizes NLGN1 from Human. This antibody is Unconjugated. Tested in the following application: ELISA, IHC;ELISA:1:2000-1:5000, IHC:1:50-1:200 |
NLGN1 Antibody |
|||
E036650 | EnoGene | 100μg/100μl | EUR 255 |
Description: Available in various conjugation types. |
NLGN1 Antibody |
|||
E046627 | EnoGene | 100μg/100μl | EUR 255 |
Description: Available in various conjugation types. |
NLGN1 Antibody |
|||
1-CSB-PA839786LA01HU | Cusabio |
|
|
Description: A polyclonal antibody against NLGN1. Recognizes NLGN1 from Human. This antibody is Unconjugated. Tested in the following application: ELISA, IHC, IF; Recommended dilution: IHC:1:20-1:200, IF:1:50-1:200 |
NLGN3 Antibody |
|||
1-CSB-PA873703LA01HU | Cusabio |
|
|
Description: A polyclonal antibody against NLGN3. Recognizes NLGN3 from Human. This antibody is Unconjugated. Tested in the following application: ELISA, IF; Recommended dilution: IF:1:200-1:500 |
NLGN1 Antibody |
|||
DF9690 | Affbiotech | 200ul | EUR 420 |
NLGN1 Antibody |
|||
DF9690-100ul | Affinity Biosciences | 100ul | EUR 280 |
NLGN1 Antibody |
|||
DF9690-200ul | Affinity Biosciences | 200ul | EUR 350 |
NLGN2 Antibody |
|||
DF9691 | Affbiotech | 200ul | EUR 420 |
Three kits (TOXO-MS, NCS-MS and NCC) showed almost perfect agreement (kappa > 0.901) with immunoblot results when the cut-offs were optimized, and one kit (NCS) proved not to be useful for detecting N. caninum seropositive SAC. By TOXO-MS ELISA, 82.3% (308/374) of the alpacas and 84.8% (167/197) of the llamas were seropositive for T. gondii, and 131/132 (99.2%) farms had seropositive animals. By NCS-MS ELISA, 3.5% (13/374) of the alpacas and 2.5% (5/197) of the llamas evidenced antibodies against N. caninum, and 9.1% (12/132) of the farms had seropositive animals.
The variables “age” and “female sex” were identified as risk factors for T. gondii infection and “absence of cats in the farm during the last two years” as a protective factor. No risk or protective factors for N. caninum infection could be identified.This nationwide cross-sectional study demonstrated for the first time the presence of antibodies against T. gondii and N. caninum in the Swiss SAC population, highlighting a high seroprevalence for T. gondii, the presence of cats as a risk factor and suggesting that SAC meat might represent an additional infection source for humans.